Tuesday, June 11, 2024

Opinion | SCOTUS’s mifepristone decision and retracted studies - The Washington Post

In March, the Supreme Court heard a case about access to mifepristone, one of two pills used for a medication abortion. Just weeks before that, though, a scientific controversy roiled the debate: Some of the scientific studies underlying the legal challenge to the abortion pill were retracted by Sage, the academic publishing company, over methodological and ethical concerns. The Supreme Court is expected to rule in a matter of days or weeks. 

This is a big deal. Removing a published article from a scientific journal doesn't happen because of some small error. It's unusual for a paper to be retracted (about 1 in 500), but the rate is increasing — and misconduct accounts for the majority of such instances. A retraction can be decided by the authors (after realizing a huge error) or by the publisher (over fraud, plagiarism, ethics, etc.).


No comments:

Post a Comment








Click Older Posts above to see more.